Company Filing History:

10 out of 3,840

Imperial Chemical Industries Limited

Cancer Research Campaign Technology Limited

6. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1983-2006

Loading Chart...

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7122551 - Metalloproteinase inhibitor compounds (2006-10-17),

2. 6734183 - Compounds (2004-05-11),

3. 6552223 - N-hydroxacylamino compounds, process for their preparation and pharmaceutical compositions containing them (2003-04-22),

4. 6436691 - Chemical compounds (2002-08-20),

5. 6277880 - Chemical compounds (2001-08-21),

6. 5981791 - High purity N-(4-[N,N-bis(2-iodoethyl)amino]phenoscycarbonyl)-L-glutamic (1999-11-09),

7. 5958971 - Chemical compounds (1999-09-28),

8. 5714148 - Chemical compounds (1998-02-03),

9. 5660829 - Process for antibody directed enzyme prodrug therapy (1997-08-26),

10. 5587161 - Prodrugs for antibody directed enzyme prodrug therapy (1996-12-24),

11. 5407945 - Pyran derivatives and their use as inhibitors of 5-lipoxygenase (1995-04-18),

12. 5405990 - Chemical compounds (1995-04-11),

13. 5276037 - Heterocyclic 5-lipoxygenase inhibitors (1994-01-04),

14. 5272173 - 5-lipoxygenase inhibitors (1993-12-21),

15. 5254581 - Pyran derivatives and their use as inhibitors of 5-lipoxygenase (1993-10-19),

Title: The Innovative Contributions of Robert I Dowell

Introduction: Robert I Dowell is an esteemed inventor based in Congleton, Great Britain, known for his groundbreaking contributions to the field of pharmaceuticals. With a remarkable portfolio of 21 patents, Dowell has made significant strides in developing compounds that play a crucial role in medical advancements.

Latest Patents: Among his latest innovations, Dowell has developed metalloproteinase inhibitor compounds. These compounds, particularly useful as inhibitors of MMP 13, hold promise in therapeutic applications. His work in this area illustrates the potential for these inventions to contribute to treatment options for various diseases.

Career Highlights: Dowell has been associated with notable companies such as Imperial Chemical Industries Limited and Zeneca Limited. His career at these prominent organizations has not only enriched his experience but also allowed him to contribute to important research and development initiatives that further the pharmaceutical sciences.

Collaborations: Throughout his career, Dowell has collaborated with remarkable colleagues including Philip John Burke and Anthony Brian Mauger. These partnerships have fostered an environment of innovation and creativity, leading to numerous successful projects and patents.

Conclusion: Robert I Dowell's contributions to the field of inventions and innovations underscore his commitment to advancing medical science. His extensive patent portfolio and collaborative efforts highlight his role as a key player in the development of new therapeutic compounds, paving the way for future breakthroughs in healthcare.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.